Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin

被引：0
|
作者：
Sharma, Manuj [1 ]
Nazareth, Irwin [1 ]
Petersen, Irene [1 ,2 ]
机构：
[1] UCL, London, England
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
730
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Charbonnel, Bernard
    Karasik, Avraham
    Liu, Ji
    Wu, Mei
    Meininger, Gary
    DIABETES CARE, 2006, 29 (12) : 2638 - 2643
  • [32] Rosiglitazone and Metformin in Patients with Type-2 Diabetes Mellitus Who are Inadequately Controlled on Metformin Alone
    Khan, M. Z. U.
    Iqbal, M. A.
    Nadeem, M. A.
    Shoaib, S.
    ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2005, 11 (01): : 20 - 23
  • [33] Efficacy and Tolerability of Vildagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy
    Goodman, M.
    Thurston, H.
    Penman, J.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (05) : 368 - 373
  • [34] Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
    Kim, Jong Ho
    Kim, Sang Soo
    Baek, Hong Sun
    Lee, In Kyu
    Chung, Dong Jin
    Sohn, Ho Sang
    Bae, Hak Yeon
    Kim, Mi Kyung
    Park, Jeong Hyun
    Choi, Young Sik
    Kim, Young Il
    Hahm, Jong Ryeal
    Lee, Chang Won
    Jo, Sung Rae
    Park, Mi Kyung
    Lee, Kwang Jae
    Kim, In Joo
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 230 - 239
  • [35] Efficacy of additional pioglitazone administration on to metformin in inadequately controlled patients with type 2 diabetes
    Kawai, Toshihide
    Funae, Osamu
    Shimada, Akira
    Hirata, Takumi
    Tabata, Mitsuhisa
    Atsumi, Yoshihito
    Itoh, Hiroshi
    DIABETES, 2007, 56 : A545 - A545
  • [36] Effectiveness and security of use of Sitagliptin in addition to an ongoing treatment by metformin in patients with non-controlled type 2 diabetes by metformin in monotherapy
    Charbonnel, B.
    Valensi, P.
    Giral, P.
    DIABETES & METABOLISM, 2007, 33 : S18 - S18
  • [37] Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin
    Ba, Jianming
    Han, Ping
    Yuan, Guoyue
    Mo, Zhaohui
    Pan, Changyu
    Wu, Fan
    Xu, Lei
    Hanson, Mary E.
    Engel, Samuel S.
    Shankar, R. Ravi
    JOURNAL OF DIABETES, 2017, 9 (07) : 667 - 676
  • [38] Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Garber, A
    Klein, E
    Bruce, S
    Sankoh, S
    Mohideen, P
    DIABETES OBESITY & METABOLISM, 2006, 8 (02): : 156 - 163
  • [39] Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
    Yu, Miao
    Shankar, R. Ravi
    Zhang, Ruya
    Zhang, Ye
    Lin, Jianxin
    O'Neill, Edward A.
    Chen, Guojuan
    Liu, Shu
    Tu, Yingmei
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 408 - 411
  • [40] Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
    Park, Hyeong Kyu
    Kim, Kyoung-Ah
    Min, Kyung-Wan
    Sohn, Tae-Seo
    Jeong, In Kyung
    Ahn, Chul Woo
    Kim, Nan-Hee
    Park, Ie Byung
    Cho, Ho Chan
    Chung, Choon Hee
    Choi, Sung Hee
    Park, Kang Seo
    Yang, Seoung-Oh
    Lee, Kwan Woo
    DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2743 - 2755
12345